-+ 0.00%
-+ 0.00%
-+ 0.00%

Pasithea Therapeutics names Kartik Krishnan chief medical officer

PUBT·05/04/2026 11:05:19
Listen to the news
Pasithea Therapeutics names Kartik Krishnan chief medical officer
  • Pasithea Therapeutics appointed Kartik Krishnan as chief medical officer, effective May 1, 2026.
  • Krishnan will lead clinical development and medical strategy as PAS-004 advances in neurofibromatosis type 1 associated plexiform and cutaneous neurofibromas.
  • He was previously CEO of OncoNano Medicines, following a stint as CMO at Arcus Biosciences.
  • Earlier roles included clinical development and medical leadership positions at Genentech, BioMarin, Amgen, Astex Pharmaceuticals, and Five Prime Therapeutics.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pasithea Therapeutics Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605040701PRIMZONEFULLFEED9711985) on May 04, 2026, and is solely responsible for the information contained therein.